Zevalin and Coma - a phase IV clinical study of FDA data

Summary:

Coma is reported as a side effect among people who take Zevalin (ibritumomab tiuxetan), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Prednisone, and have Non-hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Coma when taking Zevalin. It is created by eHealthMe based on reports of 2,256 people who have side effects when taking Zevalin from the FDA, and is updated regularly.

What is Zevalin?

Zevalin has active ingredients of ibritumomab tiuxetan. eHealthMe is studying from 2,258 Zevalin users. Check the latest studies of Zevalin.

What is Coma?

Coma (state of unconsciousness lasting more than six hours) is found to be associated with 2,812 drugs and 3,207 conditions by eHealthMe. Check the latest studies of Coma.

On Apr, 07, 2026

2,256 people reported to have side effects when taking Zevalin.
Among them, 16 people (0.71%) have Coma.

Among these 16 people:

How long have people been on Zevalin when they have Coma? *

What is the gender of people who have Coma when taking Zevalin? *

female: 46.67 %
male: 53.33 %

What is the age of people who have Coma when taking Zevalin? *

What are other drugs people take besides Zevalin? *

What are other side effects people have besides Coma? *

Thrombocytopenia (decrease of platelets in blood): 7 people, 43.75%
Haemoglobin Decreased: 4 people, 25.00%
Pneumonia: 4 people, 25.00%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 18.75%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 3 people, 18.75%
Blood Bicarbonate Decreased: 3 people, 18.75%
Breathing - Slowed Or Stopped: 3 people, 18.75%
Pleural Effusion (water on the lungs): 3 people, 18.75%
Weakness: 3 people, 18.75%
Febrile Neutropenia (fever with reduced white blood cells): 3 people, 18.75%

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 8 people, 50.00%
Thyroid Cancer: 1 person, 6.25%
Burkitt Lymphoma (cancer of the lymphatic system): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Zevalin and have Coma?

- Check whether Coma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zevalin:

Zevalin (2,258 reports)

Coma treatments and more:

Coma (57,420 reports)

Browse all side effects of Zevalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Coma:

Coma (2,812 drugs)

Browse all the conditions that are associated with Coma:

Coma (3,207 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ibritumomab tiuxetan (the active ingredients of Zevalin) and Zevalin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.